Gilead Sciences, Inc. (BIT:1GILD)
Italy flag Italy · Delayed Price · Currency is EUR
101.28
+0.18 (0.18%)
At close: Oct 10, 2025

Gilead Sciences Revenue

Gilead Sciences had revenue of $7.05B USD in the quarter ending June 30, 2025, with 2.05% growth. This brings the company's revenue in the last twelve months to $28.72B, up 3.96% year-over-year. In the year 2024, Gilead Sciences had annual revenue of $28.61B with 6.22% growth.

Revenue (ttm)
$28.72B
Revenue Growth
+3.96%
P/S Ratio
5.09
Revenue / Employee
$1.63M
Employees
17,600
Market Cap
125.09B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202428.61B1.68B6.22%
Dec 31, 202326.93B-48.00M-0.18%
Dec 31, 202226.98B-26.00M-0.10%
Dec 31, 202127.01B2.65B10.89%
Dec 31, 202024.36B2.24B10.11%
Dec 31, 201922.12B442.00M2.04%
Dec 31, 201821.68B-3.99B-15.53%
Dec 31, 201725.66B-4.29B-14.33%
Dec 31, 201629.95B-2.20B-6.84%
Dec 31, 201532.15B7.68B31.37%
Dec 31, 201424.47B13.67B126.53%
Dec 31, 201310.80B1.41B14.96%
Dec 31, 20129.40B1.01B12.08%
Dec 31, 20118.39B435.97M5.48%
Dec 31, 20107.95B938.04M13.38%
Dec 31, 20097.01B1.68B31.40%
Dec 31, 20085.34B1.11B26.14%
Dec 31, 20074.23B1.20B39.78%
Dec 31, 20063.03B997.74M49.19%
Dec 31, 20052.03B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Recordati Industria Chimica e Farmaceutica2.48B
DiaSorin1.22B
Amplifon2.41B
Philogen84.66M
EL.En.579.71M
Safilo Group998.89M
GPI S.p.A.531.42M
Pharmanutra122.25M
Revenue Rankings